Senescent prostate cancer cells secrete IL‐6, CXCL1 and CXCL2, which inhibit the activity of T cells, including both CD4+ T and CD8+ T cells, thereby promoting prostate tumour growth.18 Here, CXCL1 is linked to prostate carcinoma.